Why there is a change in the approach regarding labeling as RISK mitigation

Avatar July 24th, 2013 Posted by Zohar Peretz( ) 510(k), CE Marking, FDA, IEC60601, ISO 14971, Recall, RISK Assessment, Risk Management

A recent recall on Bryan Medical Tracoe Mini 3.0mm Tracheostomy Tube: class 1 recall – mislabeled packaging – See more at: http://www.healthcarepackaging.com/trends-and-issues/regulatory/bryan-medical-tracoe-mini-30mm-tracheostomy-tube-class-1-recall/ has proven some of the justification regarding the change in approch when putting labeling as part of the RISK mitigation. In the above case in the RISK assessment we should expect to see that not just labeling should be used to differentiate between the different devices but also packaging and coloring could be a good way to use on the device. Such mistake in labeling could affect patient safety since an oversized tracheostomy tube may cause permanent injury to the trachea. This product may cause serious adverse health consequences, including death. When we come to RISK assessment and decide to use labels as mitigation we may want to consider mistakes in packaging and address such cases as well or even perform change by design to avoid use of the device on the wrong application.


About the author, Zohar Peretz

Zohar has 18 years of experience in leading software development products, at leading software companies and startups. Using his vast experience in software development, Zohar has identified the need for a holistic solution for R&D departments, and together with Rami and a small development team, they established Orcanos ALM in 2005.

Since then, Orcanos software has evolved to other domains such as quality control and specific industries, such as medical device.

Zohar holds a BA degree in Industrial Engineering.

Tags: , , ,
Orcanos

Contact

8 Tozeret Ha'aretz Street
Tel Aviv, Israel
+972-3-5372561
info@orcanos.com

Copyright © Orcanos, All rights reserved. | Privacy policy | Terms of use